Alberto Bardelli

40PUBLICATIONS
257CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsMolecular targetsMedical infection agents (incl. prions)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (40)

|Nov 03, 2026
Calreticulin exposure is a critical mediator of high-dose vitamin C-induced immune surveillance in the tumor microenvironment.

|Jun 01, 2026
The Rising Burden of Early-Onset Cancer: Challenges and Opportunities.

|May 13, 2026
Mismatch Repair-Proficient Colorectal Cancer Can Evade Immune Surveillance through an Intrinsic Suppressive Program.

|Apr 21, 2026
Pharmacologic Inhibition of PMS2 Induces MMR Deficiency and Response to Immune Checkpoint Blockade.

|Dec 01, 2025
A subset of MMR-proficient colon cancers responds to neoadjuvant immunotherapy.

Eleonora Piumatti, Giovanni Germano, Pietro Paolo Vitiello

|Sep 24, 2025
Mismatch Repair as a Dynamic and Clinically Actionable Vulnerability in Cancer.

Eleonora Piumatti, Pietro Paolo Vitiello, Vito Amodio

Pageof 7

Frequent Collaborators

12 joint publications

Frederica Di Nicolantonio

11 joint publications

Salvatore Siena

9 joint publications

Silvia Marsoni

9 joint publications

Andrea Sartore-Bianchi